title: IFN-gamma in combination with IL-3 accelerates platelet recovery in mice with 5-fluorouracil-induced marrow aplasia.
abstract: The effects of interferon-gamma (IFN-gamma) on platelet recovery were examined in mice with marrow aplasia induced by i.p. injection of 250 mg/kg of 5-fluorouracil (5-FU). The cytokine was administrated by microosmotic pump, with an ability to deliver a consistent intact dose of cytokine for 7 consecutive days. Administration of 250 IU/kg/day of IFN-gamma in combination with 10(3) U/kg/day of IL-3, which alone had no effect on platelet counts, diminished the nadir for platelet count and shortened the duration of thrombocytopenia. The effect was comparable to that of higher doses of IL-3 (10(5) U/kg/day). The administration of 250 IU/kg/day of IFN-gamma in combination with 10(3) U/kg/day of IL-3 also induced megakaryocyte proliferation in bone marrow cell cultures. Single administration of either 250 IU/kg/day of IFN-gamma or 10(3) U/kg/day of IL-3 had no significant effects. The effect of this combination was also comparable to that of a higher dose of IL-3 (10(5) U/kg/day). We suggest that IFN-gamma accelerates megakaryocyte development, which leads to platelet production in chemotherapy-induced marrow aplasia. The administration of IFN-gamma in combination with IL-3 might be useful for the management of marrow aplasia.
authors.affiliation: Fujisaki Institute, Hayashibara Biochemical Laboratories, Okayama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tsuji-Takayama
authors.forename: A
authors.initials: A
authors.lastname: Harashima
authors.forename: H
authors.initials: H
authors.lastname: Tahata
authors.forename: N
authors.initials: N
authors.lastname: Izumi
authors.forename: Y
authors.initials: Y
authors.lastname: Nishida
authors.forename: M
authors.initials: M
authors.lastname: Namba
authors.forename: Y
authors.initials: Y
authors.lastname: Okuda
authors.forename: T
authors.initials: T
authors.lastname: Ohta
authors.forename: M
authors.initials: M
authors.lastname: Kurimoto
mesh_terms: D000741:Anemia, Aplastic / Q000139:chemically induced / Q000188:drug therapy*; D000818:Animals; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use*; D015918:Infusion Pumps, Implantable; D007371:Interferon-gamma / Q000627:therapeutic use*; D007377:Interleukin-3 / Q000627:therapeutic use*; D008533:Megakaryocytes / Q000187:drug effects; D051379:Mice; D010976:Platelet Count / Q000187:drug effects*; D011994:Recombinant Proteins; D013921:Thrombocytopenia / Q000188:drug therapy
chemical_list: D007377:Interleukin-3; D011994:Recombinant Proteins; D007371:Interferon-gamma; D005472:Fluorouracil